Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Propafenone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Propafenone 150mg tablets
0203020R0AAAAAA
|
Propafenone hydrochloride | Propafenone hydrochloride | Cardiovascular System | 4,096 |
|
Propafenone 300mg tablets
0203020R0AAABAB
|
Propafenone hydrochloride | Propafenone hydrochloride | Cardiovascular System | 930 |
|
Arythmol 150mg tablets
0203020R0BCAAAA
|
Arythmol | Propafenone hydrochloride | Cardiovascular System | 189 |
|
Arythmol 300mg tablets
0203020R0BCABAB
|
Arythmol | Propafenone hydrochloride | Cardiovascular System | 74 |
|
Propafenone 150mg/5ml oral liquid
0203020R0AAAFAF
|
Propafenone hydrochloride | Propafenone hydrochloride | Cardiovascular System | No data available |
|
Propafenone 50mg/5ml oral liquid
0203020R0AAAEAE
|
Propafenone hydrochloride | Propafenone hydrochloride | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.